Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
elraglusib (9-ING-41)
i
Other names:
9-ING-41, 9 ING 41, 9ING41
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Actuate Therap
Drug class:
GSK3β inhibitor
Related drugs:
‹
BCN057 (1)
LY2090314 (0)
BCN057 (1)
LY2090314 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF V600K
Melanoma
BRAF V600K
Melanoma
9-ING-41
Sensitive: C3 – Early Trials
9-ING-41
Sensitive
:
C3
9-ING-41
Sensitive: C3 – Early Trials
9-ING-41
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.